March 10, 2025 | CME, HOPA2025, HemOnc, OncologyEducation, VolunteerAward

Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of the 2025 HOPA Volunteer Award. Michelle is being honored for her exceptional dedication through committee and task force contributions, as well as representing the Hematology/Oncology Pharmacy Association (HOPA) at external events. Her commitment to hematology/oncology and her efforts in advancing education and collaboration make her a true leader in the field.
Reflecting on this recognition, Michelle shared, “My work in hematology/oncology is deeply personal, and I am passionate about advancing education, fostering collaboration, and ensuring we continue to elevate the standard of care for patients. Through my involvement in HOPA—whether shaping conference content, mentoring colleagues, or strategizing for the organization’s future—I’ve been fortunate to work alongside inspiring professionals who share a common goal: making a meaningful impact in oncology. I look forward to continuing this journey, driving innovation, and supporting the next generation of leaders in our field.”
Michelle will be formally honored at the 2025 HOPA Annual Conference during the Annual Member Business Meeting on Thursday, April 10th, at 10:50 AM PST.
At Medscape, we are committed to being the thread that runs through healthcare, connecting professionals with trusted education and insights that drive meaningful change. Our collective voice is one of credibility, passion, and an unwavering dedication to oncology education. Michelle’s contributions exemplify the spirit of volunteerism that strengthens the oncology community, and we celebrate her dedication to improving patient care. As we honor her remarkable achievements, we also look forward to our continued engagement at HOPA 2025.
Medscape will extend its presence at the HOPA Conference with our symposium:
Join us as we celebrate Michelle’s accomplishments and continue to advance oncology education together. Congratulations, Michelle, on this well-earned recognition!
For more information on Hematology/ Oncology Education please contact: Jelena Spyropoulos
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...
A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency
ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...
Education Supported by the National Highway Traffic Safety Administration
Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...
The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...
At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...
Across all of healthcare, a greater focus is being placed on patient centricity in order to improve outcomes and enhance patients’ quality of life. Although patient centricity is necessary in...
The Medscape team recently returned from the 9th Annual Congress of the European Academy of Neurology (EAN) in Budapest, Hungary. Among the various highlights of the congress, the team showcased...
Education on the signs, symptoms, and potential complications of cytomegalovirus (CMV) is in need of constant development, as this common disease affects nearly 1 in 3 children by age 5...
